Eastwood Bio-Medical Canada Inc. EBM.V
TSX
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 107.30K | 105.80K | 109.80K | 263.10K | 91.30K |
| Total Other Revenue | -- | -- | -- | -- | 0.00 |
| Total Revenue | 107.30K | 105.80K | 109.80K | 263.10K | 91.30K |
| Cost of Revenue | 48.70K | 21.40K | 34.70K | 70.10K | 28.20K |
| Gross Profit | 58.60K | 84.40K | 75.10K | 193.00K | 63.10K |
| SG&A Expenses | 95.60K | 110.00K | 95.20K | 216.80K | 105.50K |
| Depreciation & Amortization | 7.50K | 7.60K | 7.50K | 0.00 | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 151.70K | 139.00K | 137.40K | 286.90K | 133.70K |
| Operating Income | -44.40K | -33.20K | -27.60K | -23.80K | -42.40K |
| Income Before Tax | -48.40K | -48.40K | -14.90K | -55.40K | -42.10K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -48.40K | -48.40K | -14.90K | -55.40K | -42.10K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -48.40K | -48.40K | -14.90K | -55.40K | -42.10K |
| EBIT | -44.40K | -33.20K | -27.60K | -23.80K | -42.40K |
| EBITDA | -36.90K | -25.60K | -20.10K | -23.80K | -42.40K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Average Diluted Shares Outstanding | 68.89M | 68.89M | 68.89M | 68.89M | 68.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |